A pilot study subsequently conducted by Holst in collaboration with Mette Zander at Hvidovre Hospital between September 1999 and October 2000 indicated that continuous subcutaneous infusions of synthetic GLP-1 over 6 weeks into patients with quite severe type 2 diabetes dramatically improved their blood sugar control, lowered glycated haemoglobin levels and decreased their body weight
Many people describe eating roughly a third of what they previously ate, not through effort but because they genuinely stop feeling hungry
After the start of GLP-1RA treatment, participants were deemed to have discontinued the drug if they did not receive a refill for 90 days after their prescription ended
In midlife, it is important to get clear on the goals of nutrition and lifestyle interventions
While oral formulations offer the convenience of a pill compared to traditional injections, this shift also raises important compliance considerations
Revelations about carotid body function through its pathological role in resistant hypertension